Obviously not what I was expecting. The rumour was close enough. The IGV's you guys have worked out look pretty good. Is a resource company supposed to be worth 10% of it's IGV?
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%